Bladder Cancer

Showing NaN - NaN of 51

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

Not yet recruiting
  • Bladder Cancer
  • Scottsdale, Arizona
  • +241 more
Feb 9, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Homewood, Alabama
  • +4 more
Dec 15, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Validation for Early Cancer Detection and Minimal Residual

    Recruiting
    • Brain Cancer
    • +19 more
      • Duarte, California
      • +6 more
      Nov 10, 2022

      Bladder Cancer Trial in United States (N-803 and BCG, N-803)

      Recruiting
      • Bladder Cancer
      • Anchorage, Alaska
      • +31 more
      Oct 26, 2022

      Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)

      Completed
      • Urothelial Carcinoma
      • Bladder Cancer
      • Phoenix, Arizona
      • +27 more
      Sep 16, 2022

      Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

      Recruiting
      • Bladder Cancer
      • Hackensack, New Jersey
      • +4 more
      Aug 26, 2022

      NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • +12 more
      • Tucson, Arizona
      • +26 more
      Aug 1, 2022

      Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

      Recruiting
      • Bladder Cancer
      • +2 more
      • Tucson, Arizona
      • +76 more
      Jul 13, 2022

      Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

      Recruiting
      • Oncology
      • +16 more
      • E-602
      • Pembrolizumab
      • Grand Rapids, Michigan
      • +4 more
      May 27, 2022

      Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content, Head Neck Cancer Squamous Cell Carcinoma, NSCLC Trial in

      Recruiting
      • Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
      • +12 more
      • Palo Alto, California
      • +9 more
      Mar 24, 2022

      Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)

      Active, not recruiting
      • Bladder Cancer
      • +3 more
      • IPI-549 (eganelisib)
      • +2 more
      • Fort Wayne, Indiana
      • +28 more
      Apr 1, 2022

      Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

      Completed
      • Prostate Cancer
      • +6 more
      • MGA271
      • Los Angeles, California
      • +11 more
      Feb 4, 2022

      Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

      Terminated
      • Mesothelioma
      • +12 more
      • MGD009
      • Los Angeles, California
      • +19 more
      Feb 4, 2022

      Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

      Recruiting
      • Urothelial Carcinoma
      • +20 more
      • Gilbert, Arizona
      • +9 more
      Feb 3, 2022

      HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

      Recruiting
      • HER2-positive
      • +30 more
      • CT-0508
      • Duarte, California
      • +4 more
      Feb 1, 2022

      Bladder Cancer Trial in United States (Gemcitabine, Cisplatin, Methotrexate)

      Active, not recruiting
      • Bladder Cancer
      • Birmingham, Alabama
      • +565 more
      Dec 3, 2021

      Ovary Cancer, Cervix Cancer, Endometrium Cancer Trial in Worldwide (Tisotumab Vedotin (HuMax-TF-ADC))

      Completed
      • Ovary Cancer
      • +7 more
      • Tisotumab Vedotin (HuMax-TF-ADC)
      • Orange, California
      • +28 more
      Nov 29, 2021

      Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in Canada, United States (EDP1503,

      Completed
      • Colorectal Cancer Metastatic
      • +6 more
      • EDP1503
      • Pembrolizumab
      • Rogers, Arkansas
      • +7 more
      Nov 11, 2021